
Decoding Sarcomas: How a New Genetic Signature Could Revolutionize Cancer Risk Assessment
A revolutionary genetic signature called CINSARC offers new hope in predicting and managing metastatic risk in sarcomas, potentially changing how cancer is treated across different tumor types. Understand how this breakthrough could revolutionize cancer risk assessment and personalized treatment strategies.